NeuroVive and Sihuan Pharmaceutical have entered a collaboration agreement to develop and commercialize CicloMulsion® and NeuroSTAT® in China. Sihuan will handle clinical development, regulatory approval, and marketing in China, while NeuroVive will supply the drugs. The agreement includes upfront and milestone payments, and a royalty on net revenue. Clinical trials are planned for 2013.
documents/EFTA00589347.pdf
{}